Literature DB >> 11704316

Postoperative radiotherapy for malignant tumors of the submandibular gland.

M R Storey1, A S Garden, W H Morrison, S A Eicher, N R Schechter, K K Ang.   

Abstract

PURPOSE: This retrospective study assessed the outcome and patterns of failure for patients with malignant submandibular tumors treated with surgery and postoperative radiation. METHODS AND MATERIALS: Between 1965 and 1995, 83 patients aged 11-83 years old received postoperative radiotherapy after resection of submandibular gland carcinomas. The most common radiation technique was an appositional field to the submandibular gland bed using electrons either alone or mixed with photons. Primary tumor bed doses ranged from 50 to 69 Gy (median, 60 Gy). Regional lymph nodes (ipsilateral Levels I-IV) were irradiated in 66 patients to a median dose of 50 Gy. Follow-up time ranged from 5 to 321 months (median, 82 months).
RESULTS: Actuarial locoregional control rates were 90%, 88%, and 88% at 2, 5, and 10 years, respectively. The corresponding disease-free survival rates were 76%, 60%, and 53%, because 27 of 74 patients (36%) who attained locoregional control developed distant metastases. Adenocarcinoma, high-grade histology, and treatment during the earlier years of the study were associated with worse locoregional control and disease-free survival. The median survival times for patients with and without locoregional control were 183 months and 19 months, respectively. Actuarial 2-, 5-, and 10-year survival rates were 84%, 71%, and 55%, respectively. Late complications occurred in 8 patients (osteoradionecrosis, 5 patients).
CONCLUSIONS: High-risk cancers of the submandibular gland have a historic control rate of approximately 50% when treated with surgery alone. In the current series, locoregional control rates for high-risk patients with submandibular gland cancers treated with surgery and postoperative radiotherapy were excellent, with an actuarial locoregional control rate of 88% at 10 years.

Entities:  

Mesh:

Year:  2001        PMID: 11704316     DOI: 10.1016/s0360-3016(01)01724-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.

Authors:  Trevor M Feinstein; Stephen Y Lai; Diana Lenzner; William Gooding; Robert L Ferris; Jennifer R Grandis; Eugene N Myers; Jonas T Johnson; Dwight E Heron; Athanassios Argiris
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

2.  Oncological outcomes of patients with salivary gland cancer treated with surgery and postoperative intensity-modulated radiotherapy: a retrospective cohort study.

Authors:  Shoumei Zang; Meiqin Chen; Huijie Huang; Xinli Zhu; Xinke Li; Danfang Yan; Senxiang Yan
Journal:  Quant Imaging Med Surg       Date:  2022-05

Review 3.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

4.  Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy.

Authors:  Jae Myoung Noh; Yong Chan Ahn; Heerim Nam; Won Park; Chung-Hwan Baek; Young-Ik Son; Han-Sin Jeong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-06-30       Impact factor: 3.372

Review 5.  Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review.

Authors:  Aristeidis Chronopoulos; Theodora Zarra; Michael Ehrenfeld; Sven Otto
Journal:  Int Dent J       Date:  2017-06-25       Impact factor: 2.607

Review 6.  Management of salivary gland carcinomas - a review.

Authors:  Xiaoli Wang; Yijun Luo; Minghuan Li; Hongjiang Yan; Mingping Sun; Tingyong Fan
Journal:  Oncotarget       Date:  2017-01-17

7.  A retrospective multicenter study of carbon-ion radiotherapy for major salivary gland carcinomas: Subanalysis of J-CROS 1402 HN.

Authors:  Kazuhiko Hayashi; Masashi Koto; Yusuke Demizu; Jun-Ichi Saitoh; Hiroaki Suefuji; Tomoaki Okimoto; Tatsuya Ohno; Yoshiyuki Shioyama; Ryo Takagi; Hiroaki Ikawa; Kenji Nemoto; Takashi Nakano; Tadashi Kamada
Journal:  Cancer Sci       Date:  2018-04-27       Impact factor: 6.716

8.  Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature.

Authors:  Yongfei You; Panpan Wang; Xi Wan; Liping Xu; Yi Gong; Weihua Zhang
Journal:  Onco Targets Ther       Date:  2021-05-28       Impact factor: 4.147

9.  Dental status, dental rehabilitation procedures, demographic and oncological data as potential risk factors for infected osteoradionecrosis of the lower jaw after radiotherapy for oral neoplasms: a retrospective evaluation.

Authors:  Marcus Niewald; Jochen Fleckenstein; Kristina Mang; Henrik Holtmann; Wolfgang J Spitzer; Christian Rübe
Journal:  Radiat Oncol       Date:  2013-10-02       Impact factor: 3.481

10.  Dental status, dental treatment procedures and radiotherapy as risk factors for infected osteoradionecrosis (IORN) in patients with oral cancer - a comparison of two 10 years' observation periods.

Authors:  Marcus Niewald; Kristina Mang; Oliver Barbie; Jochen Fleckenstein; Henrik Holtmann; Wolfgang J Spitzer; Christian Rübe
Journal:  Springerplus       Date:  2014-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.